Skip to main content
Explore URMC

Golisano Children's Hospital Logo

Pediatrics / Research

 

Pediatric Research

  • Research Expertise

    Collaboration and Scientific Investigation Improve the Health of Children Worldwide

  • Developing Vaccines and Treatments to Prevent Illness and Make Children Healthier

  • Researching Ways to Reduce Healthcare Disparities and Improve Outcomes

  • Translational Research

    Bringing Discoveries and Innovations from Bench to Bedside

  • Teaching

    Developing Future Scientists Through Mentorship, Unlocking the Potential of Our Trainees

Our research has improved the health of children. A century ago, children routinely died of infections and nutritional deficiencies. A decade ago there were few treatment options for childhood cancer, premature birth, and congenital heart or brain diseases. We have made a difference in these areas. However, our work is far from done. Our challenge now is to help our patients live healthier lives as they move into adulthood. We aim to discover how to prevent childhood diseases, limit complications from treatment, and effectively manage chronic illness. Explore our research and learn more about how we plan to improve child health through research.

Research Highlights

New Vaccine Research Grant

CDC Awards Grant to the Division of Pediatric Infectious Diseases

URMC will receive $5 million over 5 years from the CDC’s New Vaccine Surveillance Network (NVSN). Geoffrey A. Weinberg, M.D. states this highly competitive award allows investigators to study the use of new vaccines and should benefit children locally and nationally.

Division of Pediatric Infectious Diseases Awarded Grant to Research New Vaccines

Photo Refugee Development

Providers Face Cultural Challenges when Evaluating Refugee Children

Numerous challenges face providers who are administering developmental screenings for refugee children, including differences in cultural and religious beliefs, language barriers, and disparate education levels, according to a study from Abigail Kroening, M.D., assistant professor of Neurodevelopmental and Behavioral Pediatrics.

Cultural Challenges Evaluating Development of Refugee Children

Neuroblastoma Cells

Neuroblastoma protein EYA1 causes cancers to become more aggressive

EYA1, a protein that contributes to ear development, is present in the cytoplasm of many neuroblastoma tumors, but this protein migrates to the nucleus in the cells of more aggressive forms of the disease. 

The discovery, made through the lab of pediatrician-in-chief Nina Schor, M.D., Ph.D., could lead to new forms of targeted therapy.

EYA1 causes cancers to become more aggressive